Harmful cholesterol levels cut in half with one-time gene editing drug in early trial

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

A Gene Editing Therapy Cut Cholesterol Levels by Half

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Scientists have edited a gene that may reduce high cholesterol permanently

Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope will be a “one and done” treatment.
Healio

Gene-editing therapy for elevated lipid levels shows promise

In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...

CRISPR gene therapy slashes 'bad' cholesterol, triglycerides by half in small study

A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half in four people taking the highest dose, raising ...